Lung function – Page 5 – Communicable Diseases Research

Comparative Study of Early Impacts of Post-COVID-19 Pneumonia on Clinical Manifestations, Pulmonary Function, and Chest Radiographs

Article

Published on 2022-02-012022-10-30
Journal: Medicina [Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] Abnormalities Adult patient age Chest chest radiographic Chest radiography clinical clinical impact clinically Comparative Comparisons conducted Control control subject cough COVID-19 cross-sectional CXR demographic Dyspnea Effect Exercise capacity fatigue FIVE Follow-up forced vital capacity function FVC group had more HADS healthy control hospital discharge Impact lesions Lung function males material mood disorders nitric oxide non-severe group non-severe patients objective participated Patient patients Pneumonia predicted pulmonary Pulmonary function test Quality of life Radiograph recruited residual symptom Result scale severe group severe pneumonia significantly lower skin rash spirometry subject Symptom the disease the healthy were assessed with COVID-19 younger people
[DOI] 10.3390/medicina58020216 PMC 바로가기 [Article Type] Article

A wearable multi-modal acoustic system for breathing analysis

호흡 분석을 위한 웨어러블 다중 모드 음향 시스템

Article

Published on 2022-02-012022-09-11
Journal: The Journal of the Acoustical Society of America [Category] COVID19(2023년), SARS, 치료기술,

Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study

Physiology

Published on 2022-01-202022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] abnormality activate Admission age Analysis Anemia apoptotic association biochemical Blood calcium ion Care caspase-3 Cell cell clearance Chest Chest CT chest infiltration coagulation analysis component Concentration Control control group controls correlated COVID-19 COVID-19 disease COVID-19 patients dehydrogenase demographic Diagnosis disease disease severity distribution Effect elevated enzyme erythrocyte evaluated exhibited expressed feature flow cytometry free hemoglobin G6PD G6PDH H b healthy controls healthy subject healthy volunteer hemoglobin Hemolysis hepatic impairment hospitalized patient hypoxia IgG IgGs Immunoglobulin infiltration Intracellular Laboratory LDH Lung function male malignancy marker material mechanical stress mechanism membrane-bound Mirror osmotic oxidative pathophysiology Patient patients performed Peripheral blood Phosphatidylserine pilot study plasma Protein pulmonary CT pulmonary infiltrate RBC RBCs reactive Red red blood cell renal Result ROS SARS-CoV-2 SARS-COV-2 infection senescent serum severe COVID-19 disease severity significant effect significantly significantly lower the disease the mean the patient the SARS-CoV-2 thrombotic Treatment virus was used were measured were recorded with COVID-19
[DOI] 10.3389/fphys.2021.825055 PMC 바로가기 [Article Type] Physiology

The Investigation of Pulmonary Function Changes of COVID-19 Patients in Three Months

Research Article

Published on 2022-01-172022-10-31
Journal: Journal of Healthcare Engineering [Category] COVID-19, SARS,

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium

Review

Published on 2022-01-132022-10-30
Journal: Medicina [Category] COVID-19,

[키워드] accelerated activate Activation adaptive affecting airway epithelial cell airway epithelial cells airway epithelium Antiviral antiviral response antiviral therapy cascade characterized contribute COPD death Defense Deterioration disease severity effective Epidemic epithelium exhibit facilitate healthy Hospitalization Host IFN IFN signaling Immune homeostasis Immunity impairment increased risk Inflammatory mediators Inhaled Interaction interferon signaling Lower respiratory tract lung lung disorder Lung function mechanism mechanisms Mortality pathogen Patient patients pulmonary inflammation reduce Research respiratory respiratory virus response resulting secondary bacterial infection secreting severe disease Signaling subsequent susceptibility susceptible the interferon therapeutic intervention understanding viral infection virus virus clearance
[DOI] 10.3390/medicina58010121 PMC 바로가기 [Article Type] Review

Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension

Research article

Published on 2022-01-012022-10-05
Journal: Medical Hypotheses [Category] 바이오마커, 변종,

[키워드] “cytokine storm” acute respiratory syndrome agonist anti-inflammatory action attenuate Autopsy blood glucose cause caused characteristic Characteristics combating coronavirus Coronavirus disease 2019 coronavirus SARS-CoV-2 COVID-19 COVID-19 infection COVID-19 patient cytokine production Cytokine storm death glucagon Glucagon like peptide-1 receptor agonists glycemic control Infectious disease inflammatory lung damage Lung function Lung injury lung tissue mice PAH pandemic Patient people with COVID-19 PHA Pneumonia Potential pulmonary arterial hypertension pulmonary inflammation recent receptor reduce Regulation responsible SARS-CoV-2 therapeutic effect therapeutic strategy Vascular
[DOI] 10.1016/j.mehy.2021.110739 [Article Type] Research article

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

Clinical Trial

Published on 2022-01-012022-10-04
Journal: EBioMedicine [Category] 바이오마커, 임상, 치료법,

[키워드] 1-year follow-up results administration adverse event analyzed antibody benefit Biomarkers Cell China clinical trial cohort study consequence COVID-19 COVID-19 patients double-blind Effectiveness enrolled evaluate Follow-up follow-up time foundation group High-resolution CT Human in both group incidence Innovation interval Lung function lung lesion Major median mesenchymal stem cell Mesenchymal stem cells treatment MSC natural Other outcome outcomes Patient phase 2 trial Placebo placebo-controlled trial plasma positive primary endpoint Program proportion Randomized RCT RCT. recorded recruited reduced Registered reported Science severe COVID-19 stem cell Symptom technology the placebo group Treatment treatment for COVID-19 Trial tumor marker two groups UC-MSC umbilical Volume walking distance
[DOI] 10.1016/j.ebiom.2021.103789 PMC 바로가기 [Article Type] Clinical Trial

ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

Article

Published on 2021-12-312022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

COVID-19 in Elderly Patients Surgically Treated for Lower Limbs Fracture

Article

Published on 2021-12-292022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Predictors of Prolonged Cardiopulmonary Exercise Impairment After COVID-19 Infection: A Prospective Observational Study

Medicine

Published on 2021-12-242022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] acute respiratory syndrome addition adjusted affected affecting age Asymptomatic BMI body mass index cardiopulmonary exercise testing contributed control group coronavirus Coronavirus disease 2019 CoV COVID-19 COVID-19 diagnosis CPET creatinine kinase Evidence exercise Exercise capacity Exercise limitation explained global pandemic impairment implication individual Infection intensive care Linear regression analysis Lung function Male sex Mild Mild symptom moderate Multiple negatively affected NT-proBNP oxygen uptake Patient patients performed physical predicted Prolonged Prospective prospective observational study R 2 reduced rehabilitation Result SARS-CoV-2 Severe case severe COVID-19 severity Sex significantly Skeletal muscle Ventilation
[DOI] 10.3389/fmed.2021.773788 PMC 바로가기 [Article Type] Medicine